The Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required) funding call from the National Institute of Mental Health (NIMH) and National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH) supports projects to elucidate the key components of the therapeutic effects of rapid-acting psychotropic interventional drugs (RAPIDs) by addressing the methodological challenges involved with these clinical trials.
This call seeks to advance understanding of how RAPIDs and adjunctive psychosocial interventions can be optimally delivered, monitored, and sustained over time to enhance effectiveness and generalizability.
Applications are open to researchers at USA-based research institutions. The award provides funding for up to 5 years.
Funding Opportunity Number: RFA-MH-27-135
Applications close on October 10, 2026.